Latest California Healthline Stories
Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug
Kaiser Health News’ Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Trump’s New Order For Medicare Packs Potential Rise In Patients’ Costs
The president’s directive, which he said is designed to give beneficiaries more choices in their health care, could lead to higher costs for seniors. Final rules are to be written by the Department of Health and Human Services.
KHN’s ‘What The Health?’: Impeachment And The Health Agenda
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Hill Hodgepodge: Pelosi Draws From Democrats, GOP And Trump For Drug Plan
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Missouri Firm With Silicon Valley Ties Faces Medicare Billing Scrutiny
Amid an overall crackdown on private insurers’ Medicare billing practices, a new government audit and a whistleblower suit allege St. Louis-based Essence Group Holdings Corp.’s Medicare Advantage plans overcharged taxpayers.
A Conservative Group Paints Trump’s Drug-Pricing Experiment As ‘Socialist.’ Is It?
The Americans for Tax Reform commercial takes too broad a brush against an initiative under consideration by the administration that would be part of the president’s promise to curb high drug prices.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.